Advanced in Ureteral Reconstruction

Dr. Mark D. Stegall

Transplant Surgery | General Surgery
200 1st St Sw, 
Rochester, MN 
Accepting New Patients
38 Years of Experience
Advanced in Ureteral Reconstruction
200 1st St Sw, 
Rochester, MN 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mark Stegall is a Transplant Surgeon and a General Surgeon in Rochester, Minnesota. Dr. Stegall has been practicing medicine for over 38 years and is rated as an Advanced provider by MediFind in Ureteral Reconstruction. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Antibody-Mediated Rejection, Obesity, Kidney Transplant, and Pancreas Transplant. Dr. Stegall is currently accepting new patients.

His clinical research consists of co-authoring 196 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Transplant Surgery
General Surgery
Licenses
Surgery in MN
Hospital Affiliations
Mayo Clinic Hospital Rochester
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Sanford
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

MAYO CLINIC
200 1st St Sw, Rochester, MN 55905

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Phase III, Prospective, Open-Label, Randomized Clinical Trial Evaluating the Augmenting of Anti-SARS-CoV2 Immunity in Kidney Transplant Recipients Via a Heterologous Additional Dose With Janssen Ad26.CoV2.S Vaccine
A Phase III, Prospective, Open-Label, Randomized Clinical Trial Evaluating the Augmenting of Anti-SARS-CoV2 Immunity in Kidney Transplant Recipients Via a Heterologous Additional Dose With Janssen Ad26.CoV2.S Vaccine
Enrollment Status: Terminated
Publish Date: September 15, 2025
Intervention Type: Biological, Other
Study Drug: Janssen Ad26.CoV2.S Vaccine
Study Phase: Phase 3
Treg Adoptive Therapy in Subclinical Inflammation in Kidney Transplantation (CTOT-21)
Treg Adoptive Therapy in Subclinical Inflammation in Kidney Transplantation (CTOT-21)
Enrollment Status: Completed
Publish Date: April 09, 2025
Intervention Type: Procedure, Drug, Biological
Study Phase: Phase 1/Phase 2
A Prospective, Randomized, Multicenter, Open-Label, Pilot Study to Investigate Medication Adherence & Patient Reported Symptom Occurrence & Interference w/ Daily Life Comparing Envarsus XR® & Immediate Release Tacrolimus in Adult Renal Transplant Recipients (SIMPLE)
A Prospective, Randomized, Multicenter, Open-Label, Pilot Study to Investigate Medication Adherence & Patient Reported Symptom Occurrence & Interference w/ Daily Life Comparing Envarsus XR® & Immediate Release Tacrolimus in Adult Renal Transplant Recipients (SIMPLE)
Enrollment Status: Active_not_recruiting
Publish Date: October 29, 2024
Intervention Type: Drug
Study Phase: Phase 4
A Randomized, Open-Label, Multi-Centre, Active Control, Efficacy and Safety Study of Imlifidase in Eliminating Donor Specific Anti-HLA Antibodies in the Treatment of Active Antibody-Mediated Rejection in Kidney Transplant Patients
A Randomized, Open-Label, Multi-Centre, Active Control, Efficacy and Safety Study of Imlifidase in Eliminating Donor Specific Anti-HLA Antibodies in the Treatment of Active Antibody-Mediated Rejection in Kidney Transplant Patients
Enrollment Status: Completed
Publish Date: February 28, 2024
Intervention Type: Drug, Other
Study Phase: Phase 2
A Phase 2, Prospective, Randomized, Multicenter, Open-Label, Controlled Trial to Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation.
A Phase 2, Prospective, Randomized, Multicenter, Open-Label, Controlled Trial to Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation.
Enrollment Status: Completed
Publish Date: October 28, 2022
Intervention Type: Drug
Study Drug: Exenatide
Study Phase: Phase 2
The TOGETHER Project - Transplant Organ Genomics to Help Prevent Rejection in Heart Transplant Recipients
The TOGETHER Project - Transplant Organ Genomics to Help Prevent Rejection in Heart Transplant Recipients
Enrollment Status: Completed
Publish Date: June 14, 2022
The Together Project-Transplant Organ Genomics to Help Prevent Rejection in Liver Transplant Recipients
The Together Project-Transplant Organ Genomics to Help Prevent Rejection in Liver Transplant Recipients
Enrollment Status: Completed
Publish Date: May 20, 2022
Intervention Type: Diagnostic test
View 6 Less Clinical Trials

196 Total Publications

Early Removal of Ureteral Stents When Attached to the Foley Catheter in Living Donor Kidney Transplant Recipients Reduces Urinary Tract Infections.
Early Removal of Ureteral Stents When Attached to the Foley Catheter in Living Donor Kidney Transplant Recipients Reduces Urinary Tract Infections.
Journal: Clinical transplantation
Published: June 27, 2025
Similar Doctors
Distinguished in Ureteral Reconstruction
Dr. Boyd R. Viers
Urology | General Surgery
Distinguished in Ureteral Reconstruction
Dr. Boyd R. Viers
Urology | General Surgery

Mayo Clinic

200 1st St Sw, 
Rochester, MN 
 (0.1 miles away)
507-284-2511
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Boyd Viers is an Urologist and a General Surgeon in Rochester, Minnesota. Dr. Viers is rated as an Elite provider by MediFind in Ureteral Reconstruction. His top areas of expertise are Urethral Stricture, Stress Urinary Incontinence, Urinary Incontinence, Reconstructive Urology Surgery, and Ureteral Reconstruction. Dr. Viers is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Stegall's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile